Search Results 1031-1040 of 21685 for Inhibition

1. Phase 1 Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of Splicing Modulator H3B-8800 for Subjects With Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia - Mayo Clinic

   Dose-optimization cohort: Prior exposure to an SF3B1 inhibitor or other spliceosome inhibitors. Participating Mayo Clinic locations. Study statuses change ...

2. Rivaroxaban Post-Transradial Access for the Prevention of Radial Artery Occlusion - Mayo Clinic

   use of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention ... Strong CYP3A4 and P-glycoprotein inhibitor use which increase ...

3. T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer - Mayo Clinic

   T-DM1, DS-8201a [trastuzumab deruxtecan]) or a HER2 targeted tyrosine kinase inhibitor (TKI) (e.g. tucatinib, lapatinib, neratinib). - Patients may have ...

4. A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence - Mayo Clinic

   ... inhibitor (CDK4/6i); Participants who received prior CDK4/6i or a poly ... Participants who received prior CDK4/6i or a poly adenosine diphosphate-ribose ...

5. An Open-label Study to Assess the Anti-Tumor Activity and Safety of REGN1979, an Anti-CD20 X Anti-CD3 Bispecific Antibody, in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   ... inhibitor. * MZL cohort: Patients with MZL that have relapsed or is refractory to at least 2 prior lines of systemic therapy. * Other B-NHL cohort: Patients ...

6. Safety and Tolerability of GTX-104 Compared With Oral Nimodipine in Patients With aSAH - Mayo Clinic

   clarithromycin, telithromycin), some anti-HIV protease inhibitors (e.g., delavirdine, indinavir, nelfinavir, ritonavir, saquinavir), some azole antimycotics ...

7. Radiation Clinical Trials - Mayo Clinic Research

   Giving MDM2 inhibitor AMG-232 and radiation therapy before surgery may make the tumor smaller and reduce the amount of normal tissue that needs to be removed. A ...

8. GRAVITAS-301: A Study Of Itacitinib Or Placebo In Combination With Corticosteroids For Treatment Of Acute Graft-Versus-Host Disease - Mayo Clinic

   Received Janus kinase (JAK) inhibitor therapy after allo-HSCT for any indication. Treatment with a JAK inhibitor before allo-HSCT is permitted. Treatment ...

9. Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Subjects With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   ... inhibitors, such as veliparib, in combination with chemotherapy followed by maintenance as initial treatment in patients with high-grade serous ovarian ...

10. Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) with Avelumab in Muscle Invasive Bladder Cancer - Mayo Clinic

    Patients who have received prior therapy with immune checkpoint inhibitors ... NOTE: Usage of non-steroidal anti-inflammatory medications (NSAIDS) for the ...